In 2017, the Health Planning Commission implemented the national version of the two-vote system: special provisions for the four cases
At 10:00 on January 9th, the National Health and Family Planning Commission convened a routine notice to the State Council's Medical Reform Office on the implementation of the "two-vote system" in the centralized procurement of pharmaceuticals in public medical institutions (for trial implementation) (hereinafter referred to as the notice) ) An official interpretation was made. The definition and significance of the two-vote system The "Notice" clarifies that the so-called two-vote system refers to the invoice issued by the pharmaceutical production enterprise to the circulation enterprise, and the circulation enterprise to open an invoice to the medical institution, and emphasizes that the two-vote system is a major measure to deepen the reform of the medical and health system and promote the healthy development of the pharmaceutical industry. It is an important means of regulating the order of drug circulation, compressing circulation links, and reducing the price of false high drugs. It is an effective means to purify the circulation environment, combat "ticket laundering" and strengthen the supervision and management of the pharmaceutical market. It is to ensure the safety of medicines for urban and rural residents and to safeguard the people. The inevitable requirement of health. Liang Wannian, director of the National Health and Family Planning Commission, said: The two-vote system is conducive to standardizing the circulation order, improving circulation efficiency and reducing the false high prices of medicines; it is conducive to strengthening drug supervision, achieving drug quality and price traceability, and safeguarding the masses. Drug safety; it is conducive to purifying the circulation, controlling the chaos in the field of drug circulation, cracking down on illegal acts such as illegal links, commercial bribery, tax evasion and tax evasion; it is conducive to deepening the reform of the pharmaceutical sector, boosting the transformation and upgrading of enterprises, and becoming bigger and stronger. Improve the concentration of the industry, promote the healthy development of the pharmaceutical industry, and achieve the "three medical linkages" reform. Scope of implementation The "Notice" proposes that public medical institutions should gradually implement the "two-vote system" in drug procurement, and encourage the "two-vote system" in drug procurement of other medical institutions. The pilot provinces (districts, municipalities) and public hospital reform pilot cities should take the lead in implementing the "two-vote system" to encourage other regions to implement the "two-vote system" and strive to push them across the country by 2018. As of December 16, 24 provinces and municipalities have expressed their attitude towards the two-vote system, actively encouraging the implementation of the "two-vote system" in the pilot cities for comprehensive reform of public hospitals, and Anhui and Hunan have issued two-vote implementation opinions. It is also clear that the two-vote system will be implemented in 2017. Special provisions for special circumstances In order to ensure the smooth landing of the two-vote system and guarantee the timely and effective supply of drugs, the "Notice" also made special provisions for special circumstances: First, in line with the development trend of modern pharmaceutical companies, a wholly-owned or holding commercial company (only one commercial company in the country) that only sells the enterprise (group) drugs established by the pharmaceutical production enterprises or the group-type enterprises integrated with science, industry and trade, The domestic distributor of overseas drugs (only one domestic general agent in the country) can be regarded as the same as the production enterprise. It is not necessary to allocate drugs to the wholly-owned (holding) subsidiaries or wholly-owned (holding) subsidiaries within the pharmaceutical circulation group-type enterprises. For one vote, but at most one invoice is allowed. Pharmaceutical production and distribution enterprises shall reasonably determine the level of mark-up according to the principles of fairness, legality and good faith. Second, in order to ensure the effective supply of grassroots medicines, it is stipulated that drug circulation enterprises should distribute medicines for townships (towns) and village medical and health institutions with special remoteness and inconvenient transportation, and allow invoices for drug purchase and sales to be opened on the basis of “two-vote systemâ€. Third, in order to deal with natural disasters, major epidemics, major emergencies and emergency (grab) rescue, the emergency procurement of drugs or national medicine reserve drugs can be implemented in special treatment. Fourth, the circulation of narcotic drugs and the first class of psychotropic drugs is still carried out in accordance with current national regulations. Liang Wannian pointed out in particular: "Special remote areas" are determined by local conditions. Even in this case, in addition to township and village-level medical institutions in remote areas, public medical institutions at or above the county level must firmly implement the "two-vote system." During the implementation of the "two-vote system", the mouth of special circumstances cannot be torn more and more, otherwise it will be out of shape; the "four votes" should be eliminated nationwide. Create conditions for the two-vote system The "Notice" pointed out that all localities and departments should actively create favorable conditions for the "two-vote system", break the barriers of interest, break local protection, support the construction of national and regional drug logistics parks and distribution centers, and promote drug circulation. The effective integration of enterprise warehousing resources and transportation resources, multi-warehouse coordinated distribution, allowing drug circulation enterprises to open positions in different places, and using the company's qualified drug warehouses and other policy measures across provinces. There are many kinds of raw materials and different properties of cosmetics. According to the properties and uses of raw materials, cosmetics can be generally divided into two categories: substrate raw materials and auxiliary raw materials. Cosmetic Ingredients ,Sodium Hyaluronate Powder,Kojic Acid Dipalmitate,Ursolic Acid Powder Xi'an Double H Health Technology Co., Ltd , https://www.dhextract.com
The former is a kind of main raw material of cosmetics, which occupies a large proportion in the formula of cosmetics, and is the substance that plays the main function in cosmetics. The latter are responsible for forming, stabilizing or giving color, fragrance and other properties of cosmetics, which are used in small amounts in cosmetic formulations but are extremely important. Cosmetics are chemical mixtures made from natural, synthetic or extracted substances with different functions, which are processed by heating, stirring and emulsifying.